Sep 16, 2026 08:31AM
Sep 16, 2026 08:30AM
Sep 15, 2026 11:10AM
Sep 15, 2026 11:10AM
Aug 4, 2026 04:01PM
Aug 4, 2026 04:01PM
Jul 21, 2026 10:00AM Gilead to present lenacapavir HIV trial data at AIDS 2026
Jul 21, 2026 10:00AM
Jun 15, 2026 04:34PM
Jun 15, 2026 04:34PM
Jun 4, 2026 04:15PM
Jun 4, 2026 04:15PM
May 21, 2026 09:30AM
May 21, 2026 09:30AM Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio
May 7, 2026 04:01PM
Apr 29, 2026 08:30AM
Apr 29, 2026 08:30AM
Apr 28, 2026 08:45AM
Apr 28, 2026 08:45AM
Apr 17, 2026 08:30AM
Apr 17, 2026 08:30AM Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
Apr 14, 2026 12:03PM
Apr 14, 2026 12:00PM
Apr 8, 2026 09:02AM
Apr 8, 2026 08:52AM
Apr 8, 2026 06:01AM
Apr 7, 2026 09:33AM
Apr 7, 2026 08:32AM Gilead Sciences to acquire Tubulis for up to $5 billion
Apr 7, 2026 08:30AM
Apr 1, 2026 04:13PM
Apr 1, 2026 04:13PM
Mar 31, 2026 06:19AM
Mar 24, 2026 03:02PM
Mar 24, 2026 06:36AM
Mar 24, 2026 05:23AM Truist on Gilead Sciences (GILD): 'old Rush: $2B Deal for Ouro Adds I&I Strength with BCMAxCD3 TCE in Orphan Autoimmune Indications
Mar 23, 2026 06:30PM
Mar 23, 2026 06:15PM
Mar 23, 2026 06:15PM
Feb 25, 2026 01:50PM
Feb 25, 2026 01:44PM
Feb 25, 2026 10:02AM
Feb 24, 2026 09:38AM Truist Securities Reiterates Buy Rating on Gilead Sciences (GILD)
Feb 24, 2026 08:23AM
Feb 23, 2026 12:32PM
Feb 23, 2026 09:31AM
Feb 23, 2026 06:01AM
Feb 23, 2026 06:01AM
Feb 17, 2026 08:30AM
Feb 10, 2026 04:01PM Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results
Dec 24, 2025 07:00AM

1,192,374 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All